Gil Beyen founded TiGenix NV. Presently, he holds the position of Chief Executive Officer & Director at ERYTech Pharma SA, President for Erytech Pharma, Inc. and Co-Managing Director at Axxis V&C BVBA. Mr. Beyen is also Commissioner for Vlaams Instituut voor Biotechnologie - Flanders Institute and on the board of 5 other companies.
In the past Gil Beyen occupied the position of Head-Life Sciences Division at Arthur D. Little, Inc. and Head-Life Sciences Division at Arthur D. Little Benelux NV (a subsidiary of Arthur D. Little, Inc.), MD, Executive Director & Chief Business Officer at TiGenix NV and Manager for Gil Beyen BVBA.
He received an MBA from The University of Chicago, a graduate degree from Université Catholique de Louvain and a graduate degree from Katholieke Universiteit Leuven.